Tahoe Therapeutics secured $30 million in funding to contribute to the global effort of sequencing one billion cells. This initiative aims to create comprehensive virtual cell models to enhance drug discovery and development using artificial intelligence. Tahoe joins nonprofit efforts like the Chan Zuckerberg Initiative, emphasizing the importance of massive single-cell datasets as foundational resources for next-generation drug development platforms.